Latest Blogs

Mar 11, 2019
For many of us not a day has gone by without some reminder of Arti, but last week brought it all back into sharp focus as I was asked to talk about the role we at ASCO played in her career during a symposium in her honor.
Mar 11, 2019
Wherever we practice, none of us need to look very far to find people who, through no fault of their own, are living right on the knife’s edge of disaster.
Mar 01, 2019
The Beirut Breast Cancer Conference is a modern multidisciplinary specialty oncology regional meeting that provides excellent onsite dissemination of knowledge and research.
Feb 27, 2019
Dr. Ashley Sumrall fulfilled a dream of performing in the famous Carnegie Hall, and discovered that the practice, teamwork, and commitment required onstage paralleled her work in oncology.
Subscribe to this column

Julie Vose, MD, MBA, FASCO

Julie M. Vose, MD, MBA, FASCO, is the 2015-2016 President of ASCO. She is the Neumann M. and Mildred E. Harris Professorial Chair and Chief of the Oncology/Hematology Division in the Department of Internal Medicine at the University of Nebraska Medical Center. She is also the Associate Director of Clinical Research at the Fred and Pamela Buffett Cancer Center.

In addition to being ASCO President, Dr. Vose also serves on the Special Awards Selection and Health Disparities Committees. An ASCO member since 1991, Dr. Vose has served on the Board of Directors, Nominating Committee, Scientific Program Committee, Hematology-Oncology Task Force, Cancer.Net Advisory Panel and Editorial Board, and Journal of Clinical Oncology Editorial Board. She served as Chair of the Cancer Education Committee and Publications Committee. Follow Dr. Vose on Twitter at @DrJulieVose.

Oct 21, 2015
Dear ASCO Member: Over the past year the American Board of Internal Medicine (ABIM) has engaged with ASCO and other stakeholders to listen to the concerns of physicians and redesign their Maintenance of Certification (MOC) program. We have advocated for reform and the ABIM is responding.  The...
Sep 22, 2015
In the latest workforce study for oncology conducted by ASCO, approximately 30% of practicing oncologists were women. However, this number is expected to grow.
Aug 04, 2015
Clinical investigation forms the backbone and the history of medical oncology. Cancer clinical trials provide the evidence we need to demonstrate safety and efficacy before Food and Drug Administration (FDA) approval and evidence for our clinical treatment guidelines. However, it seems to be more...
Jul 10, 2015
As physicians who take care of patients with cancer, all of us worldwide have the same goals of cancer prevention, early detection and screening, improvement in the quality of cancer care, and accelerating research and new therapies. The question is, how can we accomplish these goals in a world...
Jun 01, 2015
In 1964, when the first seven physicians who founded ASCO met, I doubt they imagined what a successful Society they were forming. At that time, cancer treatments were just beginning to have some early successes with a few cytotoxic therapies, new radiation modalities, and improved surgical...

Pages